The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials 2014, Vol. 11(5) 532–546, DOI: 10.1177/1740774514537404.
The calculation of the Framingham risk score presented in Table 5 of our article was incorrect.
The incorrect numbers presented in Table 5 are these:
| Characteristic | SPRINT | Intensive Treatment | Standard Treatment |
|---|---|---|---|
| 10-year Framingham risk (%) | 20.1 (10.9) | 20.1 (10.9) | 20.1 (10.8) |
The corrected numbers are these:
| Characteristic | SPRINT | Intensive Treatment | Standard Treatment |
|---|---|---|---|
| 10-year Framingham risk (%) | 24.8 (12.6) | 24.8 (12.6) | 24.8 (12.5) |
Walter T Ambrosius, Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine